During the past decade, DiskapiYBERH conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 6 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "DiskapiYBERH" #1 sponsor was "Diskapi Yildirim Beyazit Education and Research Hospital" with 6 trials, followed by "Allergan" with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "Diskapi Teaching and Research Hospital" with 1 trials sponsored and "nihal tezel" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "DiskapiYBERH" are "Cerebral Palsy" (3 trials), "Muscle Spasticity" (3 trials), "Pediatrics" (3 trials), "Cardiovascular Disease" (2 trials) and "Preoperative Anxiety" (2 trials). Many other conditions were trialed in "DiskapiYBERH" in a lesser frequency.

Most popular intervention types in "DiskapiYBERH" are "Drug" (6 trials), "Other" (4 trials), "Biological" (3 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Normal Saline (Placebo)" (2 trials), "Placebo" (2 trials), "bococizumab (PF-04950615)" (2 trials), "botulinum toxin Type A" (2 trials) and "Bevacizumab-EU" (1 trials). Other intervention names were less common.

The vast majority of trials in "DiskapiYBERH" are 13 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "DiskapiYBERH". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in DiskapiYBERH, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in DiskapiYBERH, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".